Research Article
BibTex RIS Cite
Year 2017, , 144 - 147, 15.09.2017
https://doi.org/10.5799/jmid.367556

Abstract

References

  • 1- UNAIDS Program. Access to drugs. UNAIDS Technical Update. In: UNAIDS Best Practice Collection. UNAIDS ed, Geneva, October 1998. 2- The Global Fund To Fight AIDS, Tuberculosis and Malaria. The Global Fund to Fight AIDS, Tuberculosis and Malaria announces first grants: commits up to $ 616 million over two years for prevention and treatment. Disponible sur: http://www.globalfundatm.org 3- The United States President’s Emergency Plan for AIDS Relief. Disponible sur : http://www.PEPFAR.gov 4- Eholié SP, Tanon KA, Folquet-Amorissani M, et al. Bilan de l’accès aux antirétroviraux en Côte d’Ivoire. Med Trop 2009; 69:520-524. 5- Moh R, Danel C, Messou E, et al. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa. AIDS 2007 ; 21 : 2483-91. 6- WHO. Traitement antirétroviral de l’infection à VIH chez l’adulte et l’adolescent en situation de ressources limitées: vers un accès universel: recommandations pour une approche de santé publique. – Version 2006. 7- WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010 revision. Geneva: World Health Organization; 2010. pp. 1–359 Available from http://whqlibdoc. who.int/publications/2010/9789241599764_eng.pdf 8- Nosyk B, Montaner JSG, Colley G, et al. The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study. Lancet Infect Dis 2014; 14: 40–49 9- Sow PS, Otieno LF, Bissagnene E, et al. Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries. J Acquir Immune Defic Syndr 2007; 44 : 262-7. 10- Zannou DM, Kindé-Gazard D, Vigan J, et al. Clinical and immunological profile of HIV infected patients in Cotonou, Benin. Méd Mal Infect 2004; 34: 225–228. 11- Mahy S, Duong M, Huraux J-M, and al. Mesure de l’efficacité et de l’observance du traitement antirétroviral chez des patients infectés par le VIH au Cameroun. Méd Mal Infect 2011; 41:176-180. 12- Bashi J, Balestre E, Messou E, et al. Time trends in demographic and clinical characteristics of adult patients on HAART initiation in West Africa. Med Mal Infect 2010; 40 (8):449-455. 13- Govindasamy D, Meghij J, Negussi EK, et al. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings - a systematic review. J Int AIDS Soc 2014; 17(1): 19032. 14- ONUSIDA. 90-90-90. Une cible ambitieuse de traitement pour aider à mettre fin à l’épidémie du sida. Genève, 2014; 38 p. 15- Patten GE, Wilkinson L, Conradie K, et al. Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa. J Int AIDS Soc 2013; 16:18518. 16- Rowley CF. Developments in CD4 and viral load monitoring in resource-limited settings. Clin Infect Dis 2014; 58(3):407-412.

Cascade of Care for HIV Positive Patients in a Rural Health Region in the North-Central Region of Ivory Coast: A Follow-up Study

Year 2017, , 144 - 147, 15.09.2017
https://doi.org/10.5799/jmid.367556

Abstract

Objective:
To describe the cascade of care for HIV positive patients
in the health region of Worodougou-Béré, North-Central Region of Ivory Coast.



Methods:
Cross-sectional study which included patients diagnosed
HIV positive between January 2009 and December 2012 was conducted. The analysis
focused on different steps of care, from HIV screening to antiretroviral
treatment (ART) initiation.



Results:
A total of 1659 people were diagnosed HIV positive and
992 (60%) of them were included in HIV care. Their median age and CD4 count
were 33 years [27-41 years] and 311 cells/mm3 [162-548/mm3],
respectively. Overall, 55% of them were female and 62% were symptomatic. The
proportion of eligible patients was 52%, and 81% of them started ART.



Conclusion: The cascade of HIV care
in Worodougou-Béré Region had high attrition rate. A change in strategy,
included point of care CD4 and viral load, is needed to increase access to ART
and retention in care in these rural areas. 

References

  • 1- UNAIDS Program. Access to drugs. UNAIDS Technical Update. In: UNAIDS Best Practice Collection. UNAIDS ed, Geneva, October 1998. 2- The Global Fund To Fight AIDS, Tuberculosis and Malaria. The Global Fund to Fight AIDS, Tuberculosis and Malaria announces first grants: commits up to $ 616 million over two years for prevention and treatment. Disponible sur: http://www.globalfundatm.org 3- The United States President’s Emergency Plan for AIDS Relief. Disponible sur : http://www.PEPFAR.gov 4- Eholié SP, Tanon KA, Folquet-Amorissani M, et al. Bilan de l’accès aux antirétroviraux en Côte d’Ivoire. Med Trop 2009; 69:520-524. 5- Moh R, Danel C, Messou E, et al. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa. AIDS 2007 ; 21 : 2483-91. 6- WHO. Traitement antirétroviral de l’infection à VIH chez l’adulte et l’adolescent en situation de ressources limitées: vers un accès universel: recommandations pour une approche de santé publique. – Version 2006. 7- WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010 revision. Geneva: World Health Organization; 2010. pp. 1–359 Available from http://whqlibdoc. who.int/publications/2010/9789241599764_eng.pdf 8- Nosyk B, Montaner JSG, Colley G, et al. The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study. Lancet Infect Dis 2014; 14: 40–49 9- Sow PS, Otieno LF, Bissagnene E, et al. Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries. J Acquir Immune Defic Syndr 2007; 44 : 262-7. 10- Zannou DM, Kindé-Gazard D, Vigan J, et al. Clinical and immunological profile of HIV infected patients in Cotonou, Benin. Méd Mal Infect 2004; 34: 225–228. 11- Mahy S, Duong M, Huraux J-M, and al. Mesure de l’efficacité et de l’observance du traitement antirétroviral chez des patients infectés par le VIH au Cameroun. Méd Mal Infect 2011; 41:176-180. 12- Bashi J, Balestre E, Messou E, et al. Time trends in demographic and clinical characteristics of adult patients on HAART initiation in West Africa. Med Mal Infect 2010; 40 (8):449-455. 13- Govindasamy D, Meghij J, Negussi EK, et al. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings - a systematic review. J Int AIDS Soc 2014; 17(1): 19032. 14- ONUSIDA. 90-90-90. Une cible ambitieuse de traitement pour aider à mettre fin à l’épidémie du sida. Genève, 2014; 38 p. 15- Patten GE, Wilkinson L, Conradie K, et al. Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa. J Int AIDS Soc 2013; 16:18518. 16- Rowley CF. Developments in CD4 and viral load monitoring in resource-limited settings. Clin Infect Dis 2014; 58(3):407-412.
There are 1 citations in total.

Details

Journal Section Research Article
Authors

Eboi Ehui This is me

Bashi Jules This is me

Kouakou A. Gisele This is me

Publication Date September 15, 2017
Published in Issue Year 2017

Cite

APA Ehui, E., Jules, B., & Gisele, K. A. (2017). Cascade of Care for HIV Positive Patients in a Rural Health Region in the North-Central Region of Ivory Coast: A Follow-up Study. Journal of Microbiology and Infectious Diseases, 07(03), 144-147. https://doi.org/10.5799/jmid.367556
AMA Ehui E, Jules B, Gisele KA. Cascade of Care for HIV Positive Patients in a Rural Health Region in the North-Central Region of Ivory Coast: A Follow-up Study. J Microbil Infect Dis. September 2017;07(03):144-147. doi:10.5799/jmid.367556
Chicago Ehui, Eboi, Bashi Jules, and Kouakou A. Gisele. “Cascade of Care for HIV Positive Patients in a Rural Health Region in the North-Central Region of Ivory Coast: A Follow-up Study”. Journal of Microbiology and Infectious Diseases 07, no. 03 (September 2017): 144-47. https://doi.org/10.5799/jmid.367556.
EndNote Ehui E, Jules B, Gisele KA (September 1, 2017) Cascade of Care for HIV Positive Patients in a Rural Health Region in the North-Central Region of Ivory Coast: A Follow-up Study. Journal of Microbiology and Infectious Diseases 07 03 144–147.
IEEE E. Ehui, B. Jules, and K. A. Gisele, “Cascade of Care for HIV Positive Patients in a Rural Health Region in the North-Central Region of Ivory Coast: A Follow-up Study”, J Microbil Infect Dis, vol. 07, no. 03, pp. 144–147, 2017, doi: 10.5799/jmid.367556.
ISNAD Ehui, Eboi et al. “Cascade of Care for HIV Positive Patients in a Rural Health Region in the North-Central Region of Ivory Coast: A Follow-up Study”. Journal of Microbiology and Infectious Diseases 07/03 (September 2017), 144-147. https://doi.org/10.5799/jmid.367556.
JAMA Ehui E, Jules B, Gisele KA. Cascade of Care for HIV Positive Patients in a Rural Health Region in the North-Central Region of Ivory Coast: A Follow-up Study. J Microbil Infect Dis. 2017;07:144–147.
MLA Ehui, Eboi et al. “Cascade of Care for HIV Positive Patients in a Rural Health Region in the North-Central Region of Ivory Coast: A Follow-up Study”. Journal of Microbiology and Infectious Diseases, vol. 07, no. 03, 2017, pp. 144-7, doi:10.5799/jmid.367556.
Vancouver Ehui E, Jules B, Gisele KA. Cascade of Care for HIV Positive Patients in a Rural Health Region in the North-Central Region of Ivory Coast: A Follow-up Study. J Microbil Infect Dis. 2017;07(03):144-7.